Nephrology News
Voclosporin Shows Promise as Lupus Nephritis Treatment
In a phase 2b trial, around half of patients taking the novel calcineurin inhibitor at a dose of 23.7 mg twice daily achieved complete remission at 48 weeks.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/